Microbot Medical Inc.
General ticker "MBOT" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $118.9M (TTM average)
Microbot Medical Inc. does not follow the US Stock Market performance with the rate: -12.1%.
Estimated limits based on current volatility of 4.0%: low 1.94$, high 2.10$
Factors to consider:
- Total employees count: 22 (+4.8%) as of 2023
- Top business risk factors: Going concern, Profitability concerns, Product development risks, Regulatory and compliance, Limited operating history
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.26$, 2.94$]
- 2026-12-31 to 2027-12-31 estimated range: [1.17$, 2.75$]
Financial Metrics affecting the MBOT estimates:
- Positive: with PPE of -7.3 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 95.11 > 64.29
- Negative: Industry operating cash flow per share per price (median), % of 1.51 <= 5.46
Short-term MBOT quotes
Long-term MBOT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.86MM | $11.62MM | $14.74MM |
| Operating Income | $-9.86MM | $-11.62MM | $-14.74MM |
| Non-Operating Income | $-0.89MM | $0.18MM | $1.60MM |
| R&D Expense | $5.72MM | $6.63MM | $6.28MM |
| Income(Loss) | $-10.74MM | $-11.44MM | $-13.14MM |
| Net Income(Loss)* | $-10.74MM | $-11.44MM | $-13.14MM |
| Stockholders Equity | $4.50MM | $3.53MM | $77.55MM |
| Inventory | $0.00MM | $0.00MM | $0.58MM |
| Assets | $8.33MM | $6.03MM | $81.54MM |
| Operating Cash Flow | $-8.53MM | $-8.83MM | $-13.05MM |
| Capital expenditure | $0.03MM | $0.03MM | $0.06MM |
| Investing Cash Flow | $1.97MM | $1.54MM | $-72.38MM |
| Financing Cash Flow | $6.56MM | $7.94MM | $86.24MM |
| Earnings Per Share** | $-1.05 | $-0.73 | $-0.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.